Capital Guardian Trust’s Biogen BIIB Stock Holding History

Capital Guardian Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-80	Closed	-$19K	–	235
2019 Q1	$19K	Buy	+80	New	+$25.2K	﹤0.01%	275
2017 Q2	–	Sell	-156	Closed	-$43K	–	239
2017 Q1	$43K	Sell	156 -203	-57%	-$57.4K	﹤0.01%	435
2016 Q4	$102K	Buy	359 +203	+130%	+$60.2K	﹤0.01%	402
2016 Q3	$49K	Hold	156	–	–	﹤0.01%	435
2016 Q2	$38K	Sell	156 -103	-40%	-$27.1K	﹤0.01%	455
2016 Q1	$67K	Sell	259 -122	-32%	-$32.2K	﹤0.01%	408
2015 Q4	$117K	Hold	381	–	–	﹤0.01%	388
2015 Q3	$111K	Sell	381 -18	-5%	-$5.94K	﹤0.01%	370
2015 Q2	$161K	Sell	399 -35	-8%	-$14K	﹤0.01%	350
2015 Q1	$183K	Buy	434 +88	+25%	+$34.7K	﹤0.01%	342
2014 Q4	$117K	Hold	346	–	–	﹤0.01%	349
2014 Q3	$114K	Hold	346	–	–	﹤0.01%	349
2014 Q2	$109K	Buy	346 +80	+30%	+$24.1K	﹤0.01%	337
2014 Q1	$81K	Sell	266 -109	-29%	-$34.6K	﹤0.01%	354
2013 Q4	$105K	Hold	375	–	–	﹤0.01%	334
2013 Q3	$90K	Buy	375 +140	+60%	+$31.3K	﹤0.01%	314
2013 Q2	$51K	Buy	+235	New	+$50.2K	﹤0.01%	326

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Guardian Trust's BIIB Position: Q2 2019 in Review

Capital Guardian Trust sold out of Biogen (BIIB) in Q2 2019, closing a stake of 80 shares — an estimated $19K sold.

Capital Guardian Trust first reported a position in BIIB in Q2 2013 and held it in 17 quarters. The position peaked at $183K in Q1 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

Capital Guardian Trust reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
Capital Guardian Trust sold 80 Biogen shares in Q2 2019, an estimated $19K.
Capital Guardian Trust first reported a position in Biogen in Q2 2013 and held it in 17 quarters.
Capital Guardian Trust's Biogen position peaked at $183K in Q1 2015.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.